These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 38639861)

  • 21. Lysosomal storage disorders: Clinical and therapeutic aspects.
    Pastores GM
    Handb Clin Neurol; 2023; 196():557-567. PubMed ID: 37620090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recent advances in the diagnosis and treatment of lysosomal storage diseases].
    Wu XR; Bao XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):440-4. PubMed ID: 16086072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic Stem Cell Transplantation for Neurological Disorders: A Focus on Inborn Errors of Metabolism.
    de Vasconcelos P; Lacerda JF
    Front Cell Neurosci; 2022; 16():895511. PubMed ID: 35693884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.
    Macauley SL
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):639-48. PubMed ID: 27491211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current therapeutic strategies in lysosomal disorders].
    Kaminsky P; Lidove O
    Presse Med; 2014 Nov; 43(11):1174-84. PubMed ID: 24863660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-neuronopathic lysosomal storage disorders: Disease spectrum and treatments.
    Pastores GM; Hughes DA
    Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):173-82. PubMed ID: 25987171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy for lysosomal storage disorders: a good start.
    Biffi A
    Hum Mol Genet; 2016 Apr; 25(R1):R65-75. PubMed ID: 26604151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysosomal storage diseases: current therapies and future alternatives.
    Leal AF; Espejo-Mojica AJ; Sánchez OF; Ramírez CM; Reyes LH; Cruz JC; Alméciga-Díaz CJ
    J Mol Med (Berl); 2020 Jul; 98(7):931-946. PubMed ID: 32529345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into the diagnosis and treatment of lysosomal storage diseases.
    Wenger DA; Coppola S; Liu SL
    Arch Neurol; 2003 Mar; 60(3):322-8. PubMed ID: 12633142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained Hematopoietic Engraftment Potential after Prolonged Storage of Cryopreserved Hematopoietic Stem Cells Used in Salvage Autologous Stem Cell Transplantation.
    Makhani SS; Oza SP; Reich-Slotky R; Munshi PN; Biran N; Donato ML; Siegel DS; Vesole DH; Naam S; Rowley SD
    Transplant Cell Ther; 2022 Jun; 28(6):306.e1-306.e7. PubMed ID: 35248777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newborn screening of lysosomal storage disorders.
    Marsden D; Levy H
    Clin Chem; 2010 Jul; 56(7):1071-9. PubMed ID: 20489136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene Therapy for Pediatric Neurologic Disease.
    Jimenez-Kurlander L; Duncan CN
    Hematol Oncol Clin North Am; 2022 Aug; 36(4):853-864. PubMed ID: 35760664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy for lysosomal storage disorders.
    Beck M
    IUBMB Life; 2010 Jan; 62(1):33-40. PubMed ID: 20014233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic approaches for neuronopathic lysosomal storage disorders.
    Schiffmann R
    J Inherit Metab Dis; 2010 Aug; 33(4):373-9. PubMed ID: 20162366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The basics of lysosomal storage diseases].
    Tamò R; Rohrbach M; Baumgartner M; Beuschlein F; Nowak A
    Ther Umsch; 2018 Nov; 75(4):199-207. PubMed ID: 30468118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy for the lysosomal storage disorders.
    Cabrera-Salazar MA; Novelli E; Barranger JA
    Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases.
    Krivit W
    Springer Semin Immunopathol; 2004 Nov; 26(1-2):119-32. PubMed ID: 15452666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy for lysosomal storage diseases and peroxisomal diseases.
    Ohashi T
    J Hum Genet; 2019 Feb; 64(2):139-143. PubMed ID: 30498239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases.
    Koç ON; Peters C; Aubourg P; Raghavan S; Dyhouse S; DeGasperi R; Kolodny EH; Yoseph YB; Gerson SL; Lazarus HM; Caplan AI; Watkins PA; Krivit W
    Exp Hematol; 1999 Nov; 27(11):1675-81. PubMed ID: 10560915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic approaches to lysosomal storage diseases.
    Kaye EM
    Curr Opin Pediatr; 1995 Dec; 7(6):650-4. PubMed ID: 8776014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.